Evaluation of leflunomide in patients with rheumatoid arthritis in daily clinical practice by private rheumatologists

被引：0
|
作者：
Nguyen, M
Ravaud, P
Kabir-Ahmadi, M
D'Alché-Birée, F
机构：
[1] Hosp Cochin, Rheumatol Dept B, Paris, France
[2] Hosp Bichat Claude, Paris, France
[3] Aventis Labs, Med Dept, Paris, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2003年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：413 / 413
页数：1
相关论文
共 50 条
  • [21] Leflunomide in rheumatoid arthritis in daily practice: treatment discontinuation rates in comparison with other DMARDs
    Bettembourg-Brault, I.
    Gossec, L.
    Pham, T.
    Gottenberg, J. -E.
    Damiano, J.
    Dougados, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (02) : 168 - 171
  • [22] Safety evaluation of leflunomide in rheumatoid arthritis
    Keen, Helen I.
    Conaghan, Philip G.
    Tett, Susan E.
    EXPERT OPINION ON DRUG SAFETY, 2013, 12 (04) : 581 - 588
  • [23] Rate and Causes of Infliximab Discontinuation in Patients With Rheumatoid Arthritis in a Private Clinical Practice
    Bertoli, Ana M.
    Strusberg, Ingrid
    Baravalle, Marcos
    Betelu, Zulma
    Calas, Diego
    Morales, Liliana
    Strusberg, Alberto M.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2008, 14 (06) : 313 - 317
  • [24] THE BEST SELECTION OF SECOND BIOLOGICS FOR PATIENTS WITH RHEUMATOID ARTHRITIS IN DAILY CLINICAL PRACTICE
    Saito, K.
    Nakano, K.
    Nakayamada, S.
    Kubo, S.
    Miyagawa, I.
    Hirata, S.
    Tanaka, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 513 - 513
  • [25] Prevalence of biologics monotherapy in a cohort of patients with Rheumatoid Arthritis in daily clinical practice
    Erika Catay
    Maximiliano Bravo
    Javier Rosa
    Enrique R. Soriano
    BMC Musculoskeletal Disorders, 17
  • [26] SAFETY OF JAK INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CONDITIONS OF DAILY CLINICAL PRACTICE
    Cid Boza, Natalia
    Velloso Feijoo, M. L.
    Nahia, Plaza
    Luis Marenco, Jose
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1681 - 1682
  • [27] Prevalence of biologics monotherapy in a cohort of patients with Rheumatoid Arthritis in daily clinical practice
    Catay, Erika
    Bravo, Maximiliano
    Rosa, Javier
    Soriano, Enrique R.
    BMC MUSCULOSKELETAL DISORDERS, 2016, 17
  • [28] SURVIVAL AND EFFECTIVENESS OF RITUXIMAB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS IN DAILY CLINICAL PRACTICE
    Gomez-Puerta, J. A.
    Uribe Botero, L.
    Urrego, J.
    Gonzalez, L. A.
    Ceron, C.
    Ochoa, C.
    Saldarriaga, M. A.
    Uribe Toro, A.
    Felipe Diaz, O. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1023 - 1024
  • [29] Regime of Use of Rituximab in Patients with Rheumatoid Arthritis in Daily Clinical Practice.
    Merino-Melendez, Leticia
    Llorente, Irene
    Castaneda, Santos
    Velasco, Teresa
    Sala-Icardo, Luis
    Garcia-Vicuna, Rosario
    Garcia-Vadillo, Alberto
    Lopez-Bote, Juan P.
    Lopez-Lopez, Jorge
    Herrera, Federico
    Munoz-Calleja, Cecilia
    Alvaro-Gracia, J. M.
    Gonzalez-Alvaro, Isidoro
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1051 - S1052
  • [30] Adverse events in patients with rheumatoid arthritis treated with infliximab in daily clinical practice
    Neven, N
    Vis, M
    Voskuyl, AE
    Wolbink, GJ
    Nurmohamed, MT
    Dijkmans, BAC
    Lems, WF
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (04) : 645 - 646
12345